LeMaitre Vascular Inc (LMAT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, LeMaitre Vascular Inc (LMAT) has a cash flow conversion efficiency ratio of 0.037x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($15.09 Million) by net assets ($406.62 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See LMAT defensive interval ratio to measure how many days the company can operate on defensive assets alone.
LeMaitre Vascular Inc - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how LeMaitre Vascular Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
LeMaitre Vascular Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of LeMaitre Vascular Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
TietoEVRY Corp
HE:TIETO
|
0.149x |
|
Shanghai Luxin Packing Materials Science&Technology Co Ltd
SHE:002565
|
0.007x |
|
Energa S.A.
WAR:ENG
|
0.085x |
|
Zhongfu Straits Pingtan Development Co Ltd
SHE:000592
|
0.035x |
|
Kumho Petro Chemical
KO:011780
|
0.027x |
|
Wankai New Materials Co. Ltd.
SHE:301216
|
N/A |
|
Beijing United Information Technology Co Ltd
SHG:603613
|
-0.011x |
|
Badger Infrastructure Solutions Ltd
TO:BDGI
|
0.364x |
Annual Cash Flow Conversion Efficiency for LeMaitre Vascular Inc (2004–2025)
The table below shows the annual cash flow conversion efficiency of LeMaitre Vascular Inc from 2004 to 2025. For the full company profile with market capitalisation and key ratios, see market value of LeMaitre Vascular Inc.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $393.52 Million | $81.25 Million | 0.206x | +57.83% |
| 2024-12-31 | $337.29 Million | $44.12 Million | 0.131x | +6.04% |
| 2023-12-31 | $297.90 Million | $36.75 Million | 0.123x | +30.38% |
| 2022-12-31 | $268.20 Million | $25.38 Million | 0.095x | -31.49% |
| 2021-12-31 | $254.15 Million | $35.10 Million | 0.138x | -31.51% |
| 2020-12-31 | $172.57 Million | $34.80 Million | 0.202x | +110.69% |
| 2019-12-31 | $148.14 Million | $14.18 Million | 0.096x | -36.10% |
| 2018-12-31 | $130.24 Million | $19.51 Million | 0.150x | -28.11% |
| 2017-12-31 | $109.77 Million | $22.87 Million | 0.208x | +7.89% |
| 2016-12-31 | $87.50 Million | $16.90 Million | 0.193x | +31.48% |
| 2015-12-31 | $77.88 Million | $11.44 Million | 0.147x | +81.73% |
| 2014-12-31 | $68.21 Million | $5.51 Million | 0.081x | -15.16% |
| 2013-12-31 | $56.56 Million | $5.39 Million | 0.095x | +6.69% |
| 2012-12-31 | $52.89 Million | $4.72 Million | 0.089x | +46.71% |
| 2011-12-31 | $52.09 Million | $3.17 Million | 0.061x | -54.82% |
| 2010-12-31 | $52.36 Million | $7.05 Million | 0.135x | +19.37% |
| 2009-12-31 | $48.21 Million | $5.44 Million | 0.113x | +788.45% |
| 2008-12-31 | $45.75 Million | $581.00K | 0.013x | +133.79% |
| 2007-12-31 | $48.59 Million | $-1.83 Million | -0.038x | -262.25% |
| 2006-12-31 | $50.70 Million | $-526.00K | -0.010x | +84.00% |
| 2005-12-31 | $18.54 Million | $-1.20 Million | -0.065x | -157.11% |
| 2004-12-31 | $14.81 Million | $1.68 Million | 0.114x | -- |
About LeMaitre Vascular Inc
LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in the field of vascular surgery in the Americas, Europe, the Middle Esat, Africa, and the Asia Pacific. The company offers allografts, which are cryopreserved human tissue grafts used in vascular reconstruction, and cardiac repair and reconstruction; embolectomy catheters to remove blood clots from arte… Read more